SAN DIEGO, CA — (Marketwired) — 04/24/13 — NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is pleased to announce the official opening of its Tokyo, Japan office, which will strengthen the Company’s ability to bring game-changing products, procedures, and services to the second largest spine market in the world.The Tokyo office will be headed by NuVasive’s Executive Vice President of Asia Pacific, Takaaki Tanaka. Tanaka-san has been with the Company since 2009, and brings an extensive 20 years of experience in the spine industry.
“NuVasive’s formal presence in Tokyo is a testament to our commitment to surgeon customers and their patients in Japan. We look forward to improving patient outcomes with superior clinical results as we further introduce XLIF(R) and our comprehensive spine portfolio to the Japanese market,” said Takaaki Tanaka.NuVasive recently completed several of the first eXtreme Lateral Interbody Fusion (XLIF(R)) surgical procedures in key cities and markets as a minimally disruptive option for lumbar spine fusion to patients and surgeons in Japan.
“This marks an exciting moment in NuVasive history,” said Alex Lukianov, Chairman and CEO of NuVasive. “I am especially pleased to formally open our Tokyo office. As a company, we bring a wealth of experience in spine, with proprietary innovative procedures like XLIF(R) and procedurally integrated solutions. Our initial reception in Japan has been exceptional, and I look forward to working with Tanaka-san and Russell Powers, our Executive Vice President of International, to improve spine surgery in one of the world’s largest spine markets.”
With eight international offices located in Europe, Australia, and Asia, NuVasive has a presence in over 35 countries to facilitate the proliferation of the Company’s Culture of Speed of Innovation and Absolute Responsiveness on a global basis.
About XLIF(R):
XLIF(R) is a minimally disruptive surgical procedure performed through the side of the body utilizing proprietary neuromonitoring and an integrated portfolio of instruments and specialized implants for treating a range of spinal pathologies.
Nuvasive Announces New Office in Japan
(Visited 5 times, 2 visits today)